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Por meio de técnicas cromatográficas, um novo peptídeo aniônico, denominado otacidina, foi 
isolado das secreções cutâneas de três anuros brasileiros Osteocephalus taurinus. O sequenciamento 
de novo dos aminoácidos foi realizado por meio de análises por espectrometria de massas por 
tempo de vôo acoplada à ionização dessortiva de matriz por laser (MALDI-TOF-MS/MS). O 
potencial antimicrobiano deste novo metabólito foi avaliado contra cepas de Escherichia coli e 
Pseudomonas aeruginosa, sendo observadas concentrações inibitórias mínimas (MICs) de 37,4 e 
78,4 mM, respectivamente. Este trabalho é apenas o segundo relato de um peptídeo aniônico com 
propriedades antimicrobianas, isolado da pele de um anfíbio.
By means of chromatographic techniques, a novel anionic peptide, named otacidin, was isolated 
from the skin secretions of tree Brazilian anurans Osteocephalus taurinus. The de novo sequencing 
of the amino acids was performed by matrix-assisted laser desorption ionization time-of-flight 
mass spectrometry (MALDI-TOF-MS/MS) analyses. The antimicrobial potential of this novel 
metabolite was evaluated against Escherichia coli and Pseudomonas aeruginosa, being observed 
minimum inhibitory concentration (MICs) of 37.4 and 78.4 mM, respectively. This work is just 
the second report of an antimicrobial anionic peptide from an amphibian.
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Introduction
Amphibian skin secretions comprise an alternative 
source of bioactive molecules which acts as a protection 
against microorganisms.1 These molecules are mainly toxic 
alkaloids2 and antimicrobial peptides (AMP).3 Granular 
glands in the skin of anuran amphibians, particularly those 
belonging to the families Pipidae, Hylidae, Hyperoliidae, 
Pseudidae and Ranidae, synthesize and secrete a remarkably 
diverse array of antimicrobial peptides, 10-50 residues in 
length, that are released onto the outer layer of the skin to 
provide an effective and fast-acting defense against harmful 
microorganisms.4 Antimicrobial peptides encompass a wide 
variety of structural motifs. Many peptides have α-helical 
structures. The majority of these peptides are cationic 
and amphipathic but there are also hydrophobic α-helical 
peptides which possess antimicrobial activity.5 Anionic 
antimicrobial peptides (AAMP) are very rare and their 
mode of action still is unknown.6 Osteocephalus taurinus 
is an arboreal and nocturnal frog species belonging to the 
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Hylidae family,7 which is easily found through the Central 
and North Brazil, where the mainly records are from the 
Amazon Rain Forest.8
In this Communication it is reported the identification 
of a novel anionic peptide from the skin secretions of 
the tree frog O. taurinus by means of analytical and 
preparative chromatographic methods, matrix-assisted laser 
desorption ionization time-of-flight (MALDI-TOF/TOF) 
mass spectrometry and de novo interpretation of peptide 
fragmentation spectra. The peptide was also synthesized 
and tested against several bacteria strains. 
Results and Discussion
The crude skin secretion of O. taurinus was fractionated 
by semi-preparative reversed-phase high-performance 
liquid chromatography (RP-HPLC) and yielded a number 
of unresolved fractions that were better investigated after 
at least an additional separation experiments. The fraction 
containing the peptide otacidin eluted at 37% ACN/0.1% 
TFA (trifluoroacetic acid), and after purification was 
submitted to analytical RP-HPLC due to prove its purity. 
The purified fraction in a MALDI-TOF-MS analysis showed 
the protonated molecule at m/z 1706.05 [M + H]+ and its 
sodium cluster at m/z 1728.49 [M + Na]+. The amino acid 
sequence of the new peptide named otacidin was confirmed 
by directly de novo MALDI-TOF-MS/MS sequencing 
experiments of the protonated molecule ion (Figure 1). 
The obtained sequence DSVASSAAQELSGVLASN was 
aligned in Table 1 using CLUSTAL V multiple sequence 
alignment software.9
The precursor sequence alignment of otacidin with 
other known peptide sequences using FASTA 3 program 
revealed no similar hits to this peptide confirming its 
novelty. This new peptide can be fitted into an α-helix 
type of secondary structure using theoretical information 
predicted by SOPMA program. The isoelectric point (pI) 
of otacidin was predicted by the ExPASy MW/pI tool 
program,10 which showed a pI of 3.37.
The new peptide otacidin was then synthesized by the 
solid phase approach,11 and the purified synthetic otacidin 
was evaluated in vitro for its antibacterial properties. 
Synthetic otacidin exhibited antibacterial activity against two 
human pathogenic microbial strains, namely, Escherichia 
coli and Pseudomonas aeruginosa. The minimum inhibitory 
concentration (MIC) values determined against these 
Gram-negative bacteria were 37.4 and 74.8 µM, respectively 
(Table 2). For comparison purposes, the MIC value of the 
commercial drug amoxicillin was determined showing 
variable specificities and activities (Table 2). The bactericide 
effect of otacidin was slightly higher against P. aeruginosa 
when compared to the standard drug.
Figure 1. De novo sequencing of the peptide otacidin (O. taurinus) m/z 1706.05 [M + H]+. An Applied 4700 Proteomics mass spectrometer was used 
with N2 as CID gas. The observed fragments allowed complete assignment of the major y- and b- ion series. The peptide sequence using one-letter code 
following the y- and b- series orientation is shown on the top part of the graph.
Costa et al. 2135Vol. 23, No. 12, 2012
Antimicrobial host defense peptides are widely 
distributed in animals and plants, and are the most ancient 
host defense factors. Most of these peptides have cationic 
properties12 that allow both electrostatic and hydrophobic 
interactions with the bacterial cytoplasmic membrane, which 
usually comprises negatively charged phospholipids. A few 
anionic antimicrobial peptides were previously isolated from 
sheep,12 human,13 crab,6 annelids14 and only once from a 
skin secretion of the frog Bombina maxima. 5 This type of 
AMP contains hydrophilic and acidic amino acids, which 
are opposite in charge (pI 2.5 to 3.5), and are considerably 
smaller (< 1 kDa) in size when compared with regular AMP.15 
The antimicrobial spectrum and action mechanisms are not 
established for this rare class of antimicrobial peptides. This 
work reinforces that this class exist naturally as part of the 
innate defense system of many frog species.
Conclusions
The present work describes the purification and 
characterization of a new peptide named otacidin, 
which constitutes a rare type of peptides and only the 
second example of anionic antimicrobial peptide from 
an amphibian skin. It has been speculated that the wide 
distributions of AMPs with several biological properties is 
important for the protection of these frogs against invasions 
of a wide array of different pathogens.16 With respect to 
the development of antibiotics, the current antimicrobial 
peptide otacidin provides a potential new template.
Experimental
Amphibians
Frogs skin secretions were obtained from adult 
specimens of O. taurinus (n = 7, captured in Manaus City, 
Amazon State, Brazil). Frogs were collected according to 
the Brazilian Environmental Protection Agency (IBAMA), 
under the license number 097/96-DIFAS (Process No. 
0637/91A.C).
Peptide purification
Frog secretions were obtained by mild electric stimulation 
of the skin granular glands of O. taurinus for a few seconds 
and freshly collected in distilled water. The water-soluble 
secretions from each species were filtered by gravity through 
filter paper, frozen and lyophilized. Peptide separation was 
performed by application (5 mg aliquots each time) of the 
crude extract to a semi-preparative Vydac reverse-phase (RP) 
chromatographic column, C18, 5 µm (218TP510; 10 mm × 
250 mm) in HPLC system (Shimadzu Co.) Peptides were 
purified by using linear gradients, initially 0-65% acetonitrile 
containing 0.1% TFA for 55 min. The experiments were 
monitored at 216 and 280 nm. Fractions were collected 
manually and lyophilized. The isolated fractions were 
submitted to another chromatographic step using a Vydac 
218TP54, C18, 5 µm (4.6 mm × 250 mm) analytical column, 
with optimized gradients of acetonitrile in 0.1% TFA over 
60 min.
Peptide sequencing
De novo sequencing of the otacidin was performed by 
MS/MS in a 4700 proteomics analyzer with TOF-TOF 
optics (Applied Biosystems). The MS and MS/MS 
spectra were carried out in reflector mode with external 
calibration, using the 4700 calibration mixture kit (Applied 
Table 1. Predicted fragment ions from otacidin matching the observed 
ones, within 0.1 Da mass tolerances
N-Terma Ionb y-Seriesc b-Seriesd w-b Ionse C-Termf
1 D − − 18
2 S 1590.70 203.06 17
3 V 1503.76 302.13 16
4 A 1404.69 373.17 15
5 S 1333.65 460.20 14
6 S 1246.62 547.23 13
7 A 1159.59 618.27 12
8 A 1088.55 689.31 11
9 Q 1017.52 817.36 10
10 E 889.46 946.41 9
11 L 760.42 1059.49 701.35 8
12 S 647.33 1146.52 7
13 G 560.30 1203.54 6
14 V 503.28 1302.61 5
15 L 404.21 1415.70 345.14 4
16 A 291.13 1486.73 3
17 S 220.09 1573.77 2
18 N 133.06 − 1
a,fN-and C-terminal residue positions in the peptide sequence, respectively; 
brefers to the corresponding amino acids; c,dreport the parent ion 
fragmentation pattern, following the y- and b-series, respectively; ereports 
the side-chain fragmentations that allow the discrimination of isobaric 
amino acids.




E. coli 37.4 28.0
P. aeruginosa 78.4 102.1
Isolation and Amino Acid Sequencing by MALDI-TOF-MS/MS of a Novel Antimicrobial Anionic Peptide J. Braz. Chem. Soc.2136
Biosystems). Chromatographic fractions were dissolved in 
an α-cyano-4-hydroxycinnamic acid matrix solution (1:1, 
v:v), spotted into a MALDI target plate and dried at room 
temperature for 15 min. Peptide de novo sequencing was 
performed by precursor ion fragmentation, using N2 as 
collision-induced dissociation (CID) gas. Peptide sequence 
alignments and similarity searches were performed using 
the FASTA 3 program on the ExPASy molecular server.10 
Secondary structure prediction was performed using 
SOPMA, also at this server.17
Solid phase peptide synthesis
The peptide was manually synthesized by the solid 
phase approach using the Fmoc/t-butyl chemistry,11 
according to the previous employed methodology.18
Antimicrobial tests
Antibacterial activity of otacidin against gram-negative 
bacteria was determined by the broth microdilution assay.19 
The microorganisms used were E. coli ATCC 25922 and 
P. aeruginosa ATCC 27853. The P. aeruginosa wild tipe 
(wt) strain was isolated in the Pathology Laboratory from 
the University Hospital of Brasília (HUB), Brasília City, 
Brazil. Single colonies of bacteria were inoculated into 
culture medium (3% trypticase soy broth) and cultured 
overnight at 37 °C. An aliquot of this primary culture was 
transferred to 50 mL of fresh medium and incubated for 
additional 3-6 h at 37 °C in order to obtain the cells in 
mid-logarithmic phase. The bioassays were performed by 
liquid growth inhibition assay as described by Bulet et al.20 
Otacidin was dissolved in sterile Milli-Q water and diluted 
eight-fold in trypticase soy broth (TSB; Oxoid) broth. The 
highest concentration used for the assay was 100 µmol L-1. 
The final volume was 250 µL (25 µL of the peptide test in 
water, 25 µL of the inoculums in TSB and 200 µL of TSB 
broth). After incubation for 20 h at 37 °C, the inhibition of 
bacterial growth was determined by measuring absorbance at 
595 nm. The lowest concentration of peptide that completely 
inhibited growth of the bacteria was defined as MIC. The 
MIC values were the average values obtained in triplicates, 
in three independent measurements and they were compared 
with MICs obtained for conventional antibiotics.
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